AstraZeneca Pharma India Ltd has informed that the shareholders at the 29th Annual General Meeting (AGM) of the Company held on April 28, 2008, have accorded the following:
1. The audited annual accounts for the year ended December 31, 2007 was approved.
2. Dividend @ 750% i.e. Rs 15/- per equity share of the face value Rs 2/- each was declared.
3. M/s. BSR & Co. were reappointed as the Statutory Auditors of the Company.
4. Mr. D F Udwadia, Director retiring by rotation, was re-appointed as a Director of the Company.
5. The following were appointed as Directors of the Company -
i. Mr. Graham Baker
ii. Mr. Bhasker V Iyer
6. The appointment of Mr. Anandh Balasundaram -
i. as Director of the Company and
ii. as Managing Director of the Company with effect from June 01, 2007 for a period of 5 years, was approved.
1. The audited annual accounts for the year ended December 31, 2007 was approved.
2. Dividend @ 750% i.e. Rs 15/- per equity share of the face value Rs 2/- each was declared.
3. M/s. BSR & Co. were reappointed as the Statutory Auditors of the Company.
4. Mr. D F Udwadia, Director retiring by rotation, was re-appointed as a Director of the Company.
5. The following were appointed as Directors of the Company -
i. Mr. Graham Baker
ii. Mr. Bhasker V Iyer
6. The appointment of Mr. Anandh Balasundaram -
i. as Director of the Company and
ii. as Managing Director of the Company with effect from June 01, 2007 for a period of 5 years, was approved.
No comments:
Post a Comment